P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation

American Journal of Transplantation

Volumn 6, Issue 12, 2006, Pages 2884-2893

  Pendse, S S ^a   Behjati, S ^a   Schatton, T ^a   Izawa, A ^a   Sayegh, M H ^a   Frank, M H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antigen presenting cell; CD80; Dendritic cell; Interleukin 12; P glycoprotein; Th1

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHLORDANE; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 12; INTERLEUKIN 5; VALSPODAR;

ALLOTRANSPLANTATION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TH2 CELL;

ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; P-GLYCOPROTEIN; REFERENCE VALUES; RHODAMINE 123; T-LYMPHOCYTES;

EID: 33751160779     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01561.x     Document Type: Article

References (48)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9: 10-16.
3. Blanas E, Davey GM, Carbone FR et al. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol 2000; 164: 2890-2896.
4. Gonzalo JA, Delaney T, Corcoran J et al. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation. J Immunol 2001; 166: 1-5.
5. O'Garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000; 10: 542-550.
6. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995; 154: 5071-5079.
7. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
8. Najafian N, Salama AD, Fedoseyeva EV et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252-259.
9. Stockwin LH, McGonagle D, Martin IG et al. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol Cell Biol 2000; 78: 91-102.
10. Matsue H, Kusuhara M, Matsue K et al. Dendritic cell-based immunoregulatory strategies. Int Arch Allergy Immunol 2002; 127: 251-258.
11. Thompson AG, Thomas R. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease. Immunol Cell Biol 2002; 80: 509-519.
12. Gottesman MM, Pastan I. Biochemistry of multi-drug resistance mediated by the multi-drug transporter. Annu Rev Biochem 1993; 62: 385-427.
13. Ambudkar SV, Dey S, Hrycyna CA et al. Biochemical, cellular and pharmacological aspects of the multi-drug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361-398.
14. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multi-drug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80: 2735-2739.
15. Drach D, Zhao S, Drach J et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multi-drug resistant phenotype. Blood 1992; 80: 2729-2734.
16. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537-592.
17. Pendse S, Sayegh MH, Frank MH. P-glycoprotein-a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? Curr Drug Targets 2003; 4: 469-476.
18. Klimecki WT, Futscher BW, Grogan TM et al. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83: 2451-2458.
19. Gupta S, Gollapudi S. P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol 1993; 13: 289-301.
20. Frank MH, Denton MD, Alexander SI et al. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J Immunol 2001; 166: 2451-2459.
21. Schroeijers AB, Reurs AW, Scheffer GL et al. Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol 2002; 168: 1572-1578.
22. Randolph GJ, Beaulieu S, Pope M et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A 1998; 95: 6924-6929.
23. Nagayama H, Sato K, Kawasaki H et al. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 2000; 165: 59-66.
24. Grohmann U, Fioretti MC, Bianchi R et al. Dendritic cells, interleukin 12 and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. Crit Rev Immunol 1998; 18: 87-98.
25. Rescigno M, Martino M, Sutherland CL et al. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998; 188: 2175-2180.
26. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
27. Santin AD, Hermonat PL, Ravaggi A et al. Expression of surface antigens during the differentiation of human dendritic cells versus macrophages from blood monocytes in vitro. Immunobiology 1999; 200: 187-204.
28. Thurner B, Roder C, Dieckmann D et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999; 223: 1-15.
29. Spisek R, Bretaudeau L, Barbieux I et al. Standardized generation of fully mature p70 IL-12 secreting monocyte- derived dendritic cells for clinical use. Cancer Immunol Immunother 2001; 50: 417-427.
30. Komi J, Lassila O. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000; 95: 2875-2882.
31. van Asperen J, van Tellingen O, Sparreboom A et al. Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. Br J Cancer 1997; 76: 1181-1183.
32. Advani R, Visani G, Milligan D et al. Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide and cytarabine (PSC-MEC). Adv Exp Med Biol 1999; 457: 47-56.
33. D'Andrea A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387-1398.
34. Frank NY, Pendse SS, Lapchak PH et al. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 2003; 278: 47156-47165.
35. Frank NY, Margaryan A, Huang Y et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005; 65: 4320-4333.
36. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood Mar 15 1993; 81: 1607-1613.
37. Law SK, Micklem KJ, Shaw JM et al. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol Sep 1993; 23: 2320-2325.
38. Vakkila J, Lotze MT, Riga C et al. A basis for distinguishing cultured dendritic cells and macrophages in cytospins and fixed sections. Pediatr Dev Pathol 2005; 8: 43-51.
39. de Saint-Vis B, Vincent J, Vandenabeele S et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998; 9: 325-336.
40. Grohmann U, Belladonna ML, Bianchi R et al. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 1998; 9: 315-323.
41. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995; 81: 979-982.
42. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-718.
43. Friedman ZY. Recent advances in understanding the molecular mechanisms of tamoxifen action. Cancer Invest 1998; 16: 391-396.
44. Ohishi K, Varnum-Finney B, Serda RE et al. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001; 98: 1402-1407.
45. Amsen D, Blander JM, Lee GR et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004; 117: 515-526.
46. Izawa A, Frank NY, Pendse S, Sayegh MH, Frank MH. MDRI specific pharmacologic P-glycoprotein blockade prolongs murine cardiac allograft survival. Am J Transplant 2003; 3 (5 Suppl): 447..
47. Kemnitz J, Uysal A, Haverich A et al. Multi-drug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection. J Heart Lung Transplant 1991; 10: 201-210.
48. Yousem SA, Sartori D, Sonmez-Alpan E. Multi-drug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection. J Heart Lung Transplant 1993; 12: 20-26.